Management of Heart Failure (2014)
Heart Disease is an important cause of morbidity and mortality in Malaysia. Most patients who survive a myocardial infarction or develop hypertension, will eventually develop heart failure. With ageing of the population, the prevalence of heart failure is expected to increase. Thus the publication of this Clinical Practice Guidelines on Heart Failure by the National Heart Association of Malaysia, Academy of Medicine and Ministry of Health is important and timely.
This Guidelines updates all health care providers on the latest developments in the field of Heart failure. This is the 3rd edition of the Clinical Practice Guidelines. As in previous editions, it uses an evidence based approach and grades each recommendation accordingly thus allowing the physician in charge to apply the latest technology, knowledge and standard of care in the management of his or her patient. It provides a choice of therapy and thus allows the healthcare provider to adapt this to the local situation wherever possible.
For this Clinical Practice Guidelines to be a success, it must be acceptable to our local setting and must be used widely.
Lastly, I would like to commend the Expert Committee for their hard work and effort in updating the guidelines for the benefit of all practicing physicians.
Datuk Dr. Noor Hisham Bin Abdullah
MD, MS, AM, FAMM
Director General of Health Malaysia
Ministry of Health Malaysia
Statement of intent:
This clinical practice guidelines (CPG) is meant to be a guide for clinical practice, based on the best available evidence at the time of development. Adherence to these guidelines may not necessarily guarantee the best outcome in every case. Every health care provider is responsible for the management of his/her patient based on the clinical picture presented by the patient and the management options available locally.
Period of validity
This CPG was issued in 2014 and will be reviewed in 5 years or sooner if new evidence becomes available.
Download the full document below: